Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Baxter
Colorcon
Moodys
AstraZeneca

Last Updated: May 28, 2022

LEVO-T Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Levo-t patents expire, and what generic alternatives are available?

Levo-t is a drug marketed by Cediprof Inc and is included in one NDA.

The generic ingredient in LEVO-T is levothyroxine sodium. There are ten drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

US Patents and Regulatory Information for LEVO-T

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-001 Mar 1, 2002 AB1,AB2,AB3 RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-007 Mar 1, 2002 AB1,AB2,AB3 RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-004 Mar 1, 2002 AB1,AB2,AB3 RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-011 Mar 1, 2002 AB1,AB2,AB3 RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-012 Dec 8, 2003 AB1,AB2,AB3 RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-002 Mar 1, 2002 AB1,AB2,AB3 RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-003 Mar 1, 2002 AB1,AB2,AB3 RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LEVO-T

International Patents for LEVO-T

See the table below for patents covering LEVO-T around the world.

Country Patent Number Title Estimated Expiration
Japan 2003528931 See Plans and Pricing
Australia 5295301 See Plans and Pricing
World Intellectual Property Organization (WIPO) 0174448 See Plans and Pricing
Israel 152024 PHARMACEUTICAL COMPOSITIONS CONTAINING THYROID HORMONE AND PROCESSES FOR THE MANUFACTURE THEREOF See Plans and Pricing
Canada 2404369 See Plans and Pricing
Brazil 0109736 See Plans and Pricing
Australia 2001252953 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.